Purinergic Signaling in Mast Cell Degranulation and Asthma

Mast cells are responsible for the majority of allergic conditions. It was originally thought that almost all allergic events were mediated directly only via the high-affinity immunoglobulin E receptors. However, recent evidence showed that many other receptors, such as G protein-coupled receptors and ligand-gated ion channels, are also directly involved in mast cell degranulation, the release of inflammatory mediators such as histamine, serine proteases, leukotrienes, heparin, and serotonin. These mediators are responsible for the symptoms in allergic conditions such as allergic asthma. In recent years, it has been realized that purinergic signaling, induced via the activation of G protein-coupled adenosine receptors and P2Y nucleotide receptors, as well as by ATP-gated P2X receptors, plays a significant role in mast cell degranulation. Both adenosine and ATP can induce degranulation and bronchoconstriction on their own and synergistically with allergens. All three classes of receptors, adenosine, P2X and P2Y are involved in tracheal mucus secretion. This review will summarize the currently available knowledge on the role of purinergic signaling in mast cell degranulation and its most relevant disease, asthma.

[1]  K. Jacobson,et al.  A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy , 2018, Medicinal research reviews.

[2]  Koichi Ito,et al.  UDP/P2Y6 receptor signaling regulates IgE-dependent degranulation in human basophils. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[3]  P. Barnes,et al.  Contrasting effects of ATP and adenosine on capsaicin challenge in asthmatic patients. , 2017, Pulmonary pharmacology & therapeutics.

[4]  S. Menon,et al.  Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases. , 2017, European journal of medicinal chemistry.

[5]  E. Akiva,et al.  Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor. , 2017, Cancer letters.

[6]  T. Schöneberg,et al.  Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6 , 2017, Scientific Reports.

[7]  D. Hinds,et al.  Gene‐based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling , 2017, The Journal of allergy and clinical immunology.

[8]  H. Yatsuya,et al.  Increased airway hyperresponsiveness to adenosine in patients with aspirin intolerant asthma. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[9]  I. Matsuoka,et al.  Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow‐derived mast cells , 2017, International immunopharmacology.

[10]  E. Gendaszewska-Darmach,et al.  Nucleoside 5′-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation , 2016, Oncotarget.

[11]  P. Barnes,et al.  Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases. , 2016, Chest.

[12]  Mika Watanabe,et al.  Extracellular ATP is involved in dsRNA-induced MUC5AC production via P2Y2R in human airway epithelium , 2016, Respiratory Research.

[13]  J. Linden,et al.  Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.

[14]  K. Wareham,et al.  P2X7 receptors induce degranulation in human mast cells , 2016, Purinergic Signalling.

[15]  K. Jacobson,et al.  Peripheral Adenosine A3 Receptor Activation Causes Regulated Hypothermia in Mice That Is Dependent on Central Histamine H1 Receptors , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[16]  F. Cao,et al.  Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice , 2015, Molecular medicine reports.

[17]  I. Matsuoka,et al.  P2X7 receptor antagonist activity of the anti-allergic agent oxatomide. , 2015, European journal of pharmacology.

[18]  F. Virgilio,et al.  Purinergic signaling in the immune system , 2015, Autonomic Neuroscience.

[19]  Dave Singh,et al.  The novel inhaled glucocorticoid receptor agonist GW870086X protects against adenosine-induced bronchoconstriction in asthma. , 2015, The Journal of allergy and clinical immunology.

[20]  P. Barnes,et al.  Effects of Aerosolized Adenosine 5'-Triphosphate in Smokers and Patients With COPD. , 2015, Chest.

[21]  R. Stevens,et al.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function , 2015, Molecular Pharmacology.

[22]  T. Himi,et al.  Leukotriene E4 induces MUC5AC release from human airway epithelial NCI-H292 cells. , 2015, Allergology international : official journal of the Japanese Society of Allergology.

[23]  F. Di Marco,et al.  Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double‐blind, placebo‐controlled, cross‐over study , 2015, Journal of thrombosis and haemostasis : JTH.

[24]  G. Burnstock,et al.  Purinergic signalling and immune cells , 2014, Purinergic Signalling.

[25]  K. Jacobson,et al.  The role of activated adenosine receptors in degranulation of human LAD2 mast cells , 2014, Purinergic Signalling.

[26]  R. Doukky,et al.  Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge , 2014, International journal of chronic obstructive pulmonary disease.

[27]  J. Sévigny,et al.  Histamine Induces ATP Release from Human Subcutaneous Fibroblasts, via Pannexin-1 Hemichannels, Leading to Ca2+ Mobilization and Cell Proliferation* , 2013, The Journal of Biological Chemistry.

[28]  Seiko F. Okada,et al.  Mechanosensitive ATP Release Maintains Proper Mucus Hydration of Airways , 2013, Science Signaling.

[29]  B. Fredholm,et al.  Adenosine receptors as drug targets — what are the challenges? , 2013, Nature Reviews Drug Discovery.

[30]  M. Checa,et al.  Histamine, carbachol, and serotonin induce hyperresponsiveness to ATP in guinea pig tracheas: involvement of COX-2 pathway , 2013, Pflügers Archiv - European Journal of Physiology.

[31]  K. Jacobson,et al.  The role of P2Y14 and other P2Y receptors in degranulation of human LAD2 mast cells , 2013, Purinergic Signalling.

[32]  X. Hua,et al.  Gs-Coupled Adenosine Receptors Differentially Limit Antigen-Induced Mast Cell Activation , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[33]  X. Hua,et al.  Adenosine increases nasal mucociliary clearance rate in mice through A2A and A2B adenosine receptors , 2013, The Laryngoscope.

[34]  A. Galzin,et al.  Evaluation of SSR161421, a novel orally active adenosine A3 receptor antagonist on pharmacology models. , 2013, European journal of pharmacology.

[35]  G. Grassia,et al.  Hyperresponsiveness to adenosine in sensitized Wistar rats over-expressing A1 receptor. , 2012, European journal of pharmacology.

[36]  A. Ford,et al.  A role for ATP in bronchoconstriction‐induced activation of guinea pig vagal intrapulmonary C‐fibres , 2012, The Journal of physiology.

[37]  Wei Zhao,et al.  Intracellular Adenosine Inhibits IgE-Dependent Degranulation of Human Skin Mast Cells , 2012, Journal of Clinical Immunology.

[38]  K. Ley,et al.  Regulation of Neutrophil Function by Adenosine , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[39]  X. Hua,et al.  IL-4 Amplifies the Pro-Inflammatory Effect of Adenosine in Human Mast Cells by Changing Expression Levels of Adenosine Receptors , 2011, PloS one.

[40]  H. Wise,et al.  Reciprocal modulation of anti‐IgE induced histamine release from human mast cells by A1 and A2B adenosine receptors , 2011, British journal of pharmacology.

[41]  Xi-Long Zheng,et al.  Uridine adenosine tetraphosphate induces contraction of airway smooth muscle. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[42]  P. Barnes Biochemical Basis of Asthma Therapy* , 2011, The Journal of Biological Chemistry.

[43]  A. Mukherjee,et al.  Allergic Asthma: Influence of Genetic and Environmental Factors* , 2011, The Journal of Biological Chemistry.

[44]  W. Ko,et al.  Differential Inhibitory Effects of CysLT1 Receptor Antagonists on P2Y6 Receptor-Mediated Signaling and Ion Transport in Human Bronchial Epithelia , 2011, PloS one.

[45]  Wei Zhao,et al.  Disparity in FcεRI-Induced Degranulation of Primary Human Lung and Skin Mast Cells Exposed to Adenosine , 2011, Journal of Clinical Immunology.

[46]  M. Checa,et al.  In airways ATP refills sarcoplasmic reticulum via P2X smooth muscle receptors and induces contraction through P2Y epithelial receptors , 2011, Pflügers Archiv - European Journal of Physiology.

[47]  K. Jacobson,et al.  P2Y(13) receptor is responsible for ADP-mediated degranulation in RBL-2H3 rat mast cells. , 2010, Pharmacological research.

[48]  M. Idzko,et al.  Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity , 2010, The Journal of experimental medicine.

[49]  T. Zuberbier,et al.  Mast cell lines HMC‐1 and LAD2 in comparison with mature human skin mast cells – drastically reduced levels of tryptase and chymase in mast cell lines , 2010, Experimental dermatology.

[50]  A. Nadeem,et al.  Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. , 2010, American journal of physiology. Heart and circulatory physiology.

[51]  D. Mitchell,et al.  Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. , 2010, American journal of respiratory cell and molecular biology.

[52]  T. Kawakami,et al.  FcεRI β‐chain ITAM amplifies PI3K‐signaling to ensure synergistic degranulation response via FcεRI and adenosine receptors , 2010, European journal of immunology.

[53]  K. Jacobson,et al.  UDP‐glucose acting at P2Y14 receptors is a mediator of mast cell degranulation , 2010, Biochemical pharmacology.

[54]  S. Bulfone-Paus,et al.  P2 receptor-mediated signaling in mast cell biology , 2010, Purinergic Signalling.

[55]  M. Trevethick,et al.  Design and application of locally delivered agonists of the adenosine A2A receptor , 2010, Expert review of clinical pharmacology.

[56]  E. R. Mcfadden,et al.  Safety of Binodenoson, a Selective Adenosine A2A Receptor Agonist Vasodilator Pharmacological Stress Agent, in Healthy Subjects With Mild Intermittent Asthma , 2009, Circulation. Cardiovascular imaging.

[57]  K. Wareham,et al.  Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells , 2009, British journal of pharmacology.

[58]  Bulanova Elena,et al.  ATP induces P2X7 receptor‐independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells , 2009 .

[59]  G. Tamura,et al.  Regulation of adenosine 5′-triphosphate (ATP)-gated P2X4 receptors on tracheal smooth muscle cells , 2009, Respiratory Physiology & Neurobiology.

[60]  J. Linden,et al.  Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. , 2008, American journal of physiology. Heart and circulatory physiology.

[61]  R. Tarran,et al.  A2B adenosine receptors regulate the mucus clearance component of the lung's innate defense system. , 2008, American journal of respiratory cell and molecular biology.

[62]  I. Biaggioni,et al.  Effect of A2B Adenosine Receptor Gene Ablation on Proinflammatory Adenosine Signaling in Mast Cells1 , 2008, The Journal of Immunology.

[63]  N. Nakatsuji,et al.  Direct Development of Functionally Mature Tryptase/Chymase Double‐Positive Connective Tissue‐Type Mast Cells from Primate Embryonic Stem Cells , 2008, Stem cells.

[64]  I. Biaggioni,et al.  Effect of A2B Adenosine Receptor Gene Ablation on Adenosine-Dependent Regulation of Proinflammatory Cytokines , 2008, Journal of Pharmacology and Experimental Therapeutics.

[65]  M. Breschi,et al.  In vivo adenosine A(2B) receptor desensitization in guinea-pig airway smooth muscle: implications for asthma. , 2007, European journal of pharmacology.

[66]  X. Hua,et al.  Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[67]  Tiejuan Mi,et al.  Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[68]  K. Kamiya,et al.  Roles of P2X receptors and Ca2+ sensitization in extracellular adenosine triphosphate‐induced hyperresponsiveness in airway smooth muscle , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[69]  M. Blackburn,et al.  A3 adenosine receptor signaling contributes to airway mucin secretion after allergen challenge. , 2006, American journal of respiratory cell and molecular biology.

[70]  K. Jacobson,et al.  Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.

[71]  K. Jacobson,et al.  CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. , 2005, Biochemical pharmacology.

[72]  M. Inoue,et al.  Human adenosine A3 receptor leads to intracellular Ca2+ mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase γ in mice , 2005 .

[73]  P. Barnes,et al.  Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. , 2005, Chest.

[74]  K. Jacobson,et al.  Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. , 2005, Blood.

[75]  D. Zeng,et al.  The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma. , 2005, Bioorganic & medicinal chemistry letters.

[76]  M. Gallup,et al.  Adenosine up‐regulation of the mucin gene, MU2, in asthma , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  James J. Lee,et al.  A3 Adenosine Receptor Signaling Contributes to Airway Inflammation and Mucus Production in Adenosine Deaminase-Deficient Mice1 , 2004, The Journal of Immunology.

[78]  D. Adriaensen,et al.  Purinergic signalling in the lung: important in asthma and COPD? , 2004, Current opinion in pharmacology.

[79]  D. Metcalfe,et al.  Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. , 2003, Leukemia research.

[80]  G. Nilsson,et al.  Activation of mast cells by immunoglobulin E‐receptor cross‐linkage, but not through adenosine receptors, induces A1 expression and promotes survival , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[81]  M. Jacobson,et al.  References Subscriptions Permissions Email Alerts A Class I MHC-Restricted Recall Response to a Viral Peptide Is Highly Polyclonal Despite Stringent CDR3 Selection: Implications for Establishing Memory T Cell Repertoires in ''Real-World' ' Conditions , 2013 .

[82]  M. Tsai,et al.  Identification of A3 Receptor- and Mast Cell-Dependent and -Independent Components of Adenosine-Mediated Airway Responsiveness in Mice1 , 2003, The Journal of Immunology.

[83]  J. Fozard The case for a role for adenosine in asthma: almost convincing? , 2003, Current opinion in pharmacology.

[84]  K. Broadley,et al.  Mediators of adenosine- and ovalbumen-induced bronchoconstriction of sensitized guinea-pig isolated airways. , 2002, European journal of pharmacology.

[85]  J. Fozard,et al.  Suppression of Adenosine A3 Receptor-Mediated Hypotension and Mast Cell Degranulation in the Rat by Dexamethasone , 2002, Journal of Pharmacology and Experimental Therapeutics.

[86]  D. Kellerman P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance. , 2002, Chest.

[87]  Chang Jong Kim,et al.  ATP-induced histamine release is in part related to Phospholipase A2- mediated arachidonic acid metabolism in rat peritoneal mast cells , 2001, Archives of pharmacal research.

[88]  Beverly H. Koller,et al.  Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells* , 2000, The Journal of Biological Chemistry.

[89]  M. Jacobson,et al.  Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. , 2000, The Journal of clinical investigation.

[90]  M. K. James,et al.  Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep. , 1999, Journal of applied physiology.

[91]  A. Korngreen,et al.  Extracellular sodium regulates airway ciliary motility by inhibiting a P2X receptor , 1999, Nature.

[92]  J. Butterfield,et al.  ATP modulates anti-IgE-induced release of histamine from human lung mast cells. , 1999, American journal of respiratory cell and molecular biology.

[93]  B. Fredholm,et al.  Caffeine--an atypical drug of dependence. , 1998, Drug and alcohol dependence.

[94]  Hidefumi Suzuki,et al.  Inhibitory Effect of Adenosine on Degranulation of Human Cultured Mast Cells upon Cross-linking of FcϵRI , 1998 .

[95]  R. K. Shepherd,et al.  Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. , 1997, The Journal of clinical investigation.

[96]  J. Linden,et al.  Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. , 1997, Molecular pharmacology.

[97]  J. J. Reeves,et al.  Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo , 1997, Inflammation Research.

[98]  J. Nyce,et al.  DNA antisense therapy for asthma in an animal model , 1997, Nature.

[99]  R. K. Shepherd,et al.  Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor. , 1996, Circulation research.

[100]  P. von Wichert,et al.  Effects of selective and non-selective phosphodiesterase inhibitors on tracheal mucus secretion in the rat. , 1996, European journal of pharmacology.

[101]  J. Fozard,et al.  Mast cell degranulation following adenosine A3 receptor activation in rats. , 1996, European journal of pharmacology.

[102]  I. Biaggioni,et al.  Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. , 1995, The Journal of clinical investigation.

[103]  T. Gettys,et al.  Dexamethasone up-regulates A3 adenosine receptors in rat basophilic leukemia (RBL-2H3) cells. , 1995, Journal of immunology.

[104]  D. Marquardt,et al.  Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. , 1994, Journal of immunology.

[105]  A. Yen,et al.  IgE and adenosine 5' triphosphate receptors on immature murine mast cells are functionally linked to signal transduction mechanisms. , 1992, The Journal of allergy and clinical immunology.

[106]  G. Stiles,et al.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Z. Jaffar,et al.  Histamine secretion from mast cells stimulated with ATP , 1990, Agents and Actions.

[108]  J. Cunha-Melo,et al.  Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 cells. Evidence for a novel adenosine receptor. , 1990, The Journal of biological chemistry.

[109]  J. Cunha-Melo,et al.  Treatment with dexamethasone down-regulates IgE-receptor-mediated signals and up-regulates adenosine-receptor-mediated signals in a rat mast cell (RBL-2H3) line. , 1990, Journal of immunology.

[110]  I. Ziment Theophylline and mucociliary clearance. , 1987, Chest.

[111]  M. Lohse,et al.  Dual actions of adenosine on rat peritoneal mast cells , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

[112]  A. Wanner Effects of methylxanthines on airway mucociliary function. , 1985, The American journal of medicine.

[113]  S. Holgate,et al.  Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. , 1984, Biochemical pharmacology.

[114]  S. Holgate,et al.  Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. , 1984, The American review of respiratory disease.

[115]  S. Holgate,et al.  Adenosine inhibits and potentiates IgE‐dependent histamine release from human basophils by an A2‐receptor mediated mechanism , 1983, British journal of pharmacology.

[116]  G. Schultze-Werninghaus,et al.  The clinical and pharmacological history of theophylline: first report on the bronchospasmolytic action in man by S. R. Hirsch in Frankfurt (Main) 1922 , 1982, Clinical allergy.

[117]  R. Rothstein Intravenous theophylline therapy in asthma: a clinical update. , 1980, Annals of emergency medicine.

[118]  T. Sullivan,et al.  Potentiation of mast cell mediator release by adenosine. , 1978, Journal of immunology.

[119]  R. Whelan The role of histamine. , 1960, American heart journal.

[120]  M. Sitkovsky,et al.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases , 2017, Nature Reviews Rheumatology.

[121]  C. Billington,et al.  β2 Agonists. , 2017, Handbook of experimental pharmacology.

[122]  Qun Zhou,et al.  [Effect of aminophylline and simvastatin on airway inflammation and mucus hypersecretion in rats with chronic obstructive pulmonary disease]. , 2016, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[123]  R. Stevens,et al.  Nucleotides Acting at P 2 Y Receptors : Connecting Structure and Function , 2015 .

[124]  Xiaowei Jin,et al.  Inosine Binds to A 3 Adenosine Receptors and Stimulates Mast Cell Degranulation , 2013 .

[125]  L. Donnelly,et al.  Therapy for Chronic Obstructive Pulmonary Disease in the 21st Century , 2012, Drugs.

[126]  K. Jacobson,et al.  Xanthines as adenosine receptor antagonists. , 2011, Handbook of experimental pharmacology.

[127]  J. Fozard From Hypertension (+) to Asthma: Interactions with the Adenosine A 3 Receptor from a Personal Perspective , 2010 .

[128]  A. Nadeem,et al.  Involvement of A 1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma , 2010 .

[129]  K. Wareham,et al.  Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells , 2009, British journal of pharmacology.

[130]  F. Koch-Nolte,et al.  ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells. , 2009, Journal of Leukocyte Biology.

[131]  J. Linden,et al.  Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. , 2008, American journal of physiology. Heart and circulatory physiology.

[132]  M. Inoue,et al.  Human adenosine A(3) receptor leads to intracellular Ca(2+) mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase gamma in mice. , 2005, Biochemical Pharmacology.

[133]  G. Burnstock,et al.  Immunolocalisation of P2X and P2Y nucleotide receptors in the rat nasal mucosa , 2004, Cell and Tissue Research.

[134]  M. King,et al.  Effect of aerosolized uridine-5'-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia. , 1999, American journal of respiratory and critical care medicine.

[135]  T. Nakahata,et al.  Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI. , 1998, Biochemical and biophysical research communications.

[136]  R. Pauwels,et al.  Characterization of the adenosine receptors in the airways. , 1995, Archives internationales de pharmacodynamie et de therapie.

[137]  G. Dewald,et al.  Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.

[138]  S. Holgate,et al.  The role of histamine in allergen and adenosine-induced bronchoconstriction. , 1987, International archives of allergy and applied immunology.

[139]  The Inhibitory Effect , 2022 .